Entyvio (vedolizumab) is a prescription drug used to treat Crohn’s disease and ulcerative colitis. Its mechanism of action (how it works) is to block specific inflammatory cells from entering the gut.
Entyvio is a brand-name biologic drug administered through intravenous (IV) infusion or subcutaneous injection to treat moderate to severe ulcerative colitis and Crohn’s disease, with the goal of ...
− ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy “With the FDA approval of subcutaneous ENTYVIO, patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results